Ireland
--:--IST
Latest
Clinical Trials in Israel / NCT06591247
Recruiting Not applicable

Membrane Stripping for Cervical Ripening

NCT06591247 · tracked via the Priya Life Science Israel tracker
Phase
Not applicable
Started
2024-08-07
Last updated
2026-04-15

Condition(s) studied

Labor, InducedCervical RipeningBalloon InductionMembrane StrippingPregnancy RelatedInduction of Birth

Investigational drug(s) / intervention(s)

Double Baloon CatheterMembrane StrippingPGE2

Double Baloon Catheter: A double Baloon Catheter will be inserted for 12 hours to one of the arms of the study

Membrane Stripping: Stripping will be considered as 3-5 rotations of separating the amniotic sac from the cervix and will be perfomed twice (every 4-6 hours)

PGE2: A PGE2 vaginal pessary (Cervidil) will be inserted for 12-24 hours

Study summary

The goal of this interventional study is to evaluate the effectiveness of membrane stripping in cervical ripening compared to double balloon catheter induction.

The study population consists of women undergoing labor induction.

The main questions it aims to answer are:

1. Is membrane stripping as effective as double balloon catheter induction in cervical ripening?
2. What is the influence of membrane stripping on the time required for cervical ripening, delivery duration, and maternal and fetal outcomes compared to balloon induction.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Patients aged 18 and above * Patients with a cervical dilation of at least 1 cm * Full-term pregnancy * Cephalic presentation * No contraindication to vaginal delivery Exclusion Criteria: * Patients with rupture of membranes * Patients who do not require cervical ripening and proceed directly to the delivery room for induction with oxytocin * Patients for whom the use of a double-balloon catheter/PGE2 is contraindicated * Twin pregnancies * Pregnancies with macrosomic fetuses where vaginal delivery is contraindicated * Patients with maternal or fetal pathologies that do not allow for vaginal delivery due to concerns about fetal or maternal distress

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Meir Medical Center Kfar Saba Central District Recruiting

More Meir Medical Center trials in Israel

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06591247 on ClinicalTrials.gov ↗ ← All trials in Israel